Follow the 이엔셀 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 이엔셀 has recorded 5 insider filings. Market capitalisation: €95.9bn. The latest transaction was disclosed on 2 April 2026 (Sale). Among the most active insiders: 장종욱. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations